Conmed (CNMD) Interest Expenses (2010 - 2026)

Conmed has reported Interest Expenses for 17 years, with the latest figure at $7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 14.8% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (up 82.04% YoY), and the FY2025 full-year result was $418000.0, changed N/A from the prior year.
• Interest Expenses for Q1 2026 stood at $7.1 million, down from $7.6 million in the prior quarter.
• The five-year high for Interest Expenses was $112.0 million in Q2 2022, with the low at -$83.1 million in Q4 2022.
• Historically, Interest Expenses has averaged $5.6 million across 5 years, with a median of $7.9 million in 2025.
• The largest YoY upside for Interest Expenses was 105.18% in 2023 against a maximum downside of 91.07% in 2023.
• Conmed's Interest Expenses stood at -$83.1 million in 2022, then soared by 63.58% to -$30.3 million in 2023, then surged by 131.69% to $9.6 million in 2024, then retreated by 20.72% to $7.6 million in 2025, then decreased by 7.18% to $7.1 million in 2026.
• The last three Interest Expenses figures came in at $7.1 million (Q1 2026), $7.6 million (Q3 2025), and $418000.0 (Q2 2025), per Business Quant data.